Skip to main content

Live Attenuated Vaccines Market is Systematically Increasing at a Healthy CAGR of 10.7% During Forecast to 2023

Market Outlook:
The economic strain caused by livestock and zoonotic diseases are likely to trigger the demand for LAVs. In 2001, the Foot and Mouth Disease (FMD) had cost the government in the U.K. close to USD 3.7 billion. Regulations by international health organizations for the use of livestock attenuated vaccines to control the spread of infectious diseases can augur favorably for the market. Benefits such as improved animal health, reduced antimicrobial use, and improvements for the welfare of the public will ensure in the production of LAVs.
The global Live Attenuated Vaccines Market valuation can touch USD 45.2 billion by 2023. It stood at USD 34.2 billion in 2016. The market is predicted to display a CAGR of 10.7% over the forecast period. Awareness of vaccines, rise in government funds for vaccination programs, and prevalence of livestock diseases are major drivers of the market. The improvement in healthcare infrastructure, presence of veterinarians in rural areas, and efforts for prevention of infectious diseases are other drivers.
However, restriction on the use of vaccines on some diseases can hamper the market growth.
Competitive Outlook:
CSL Limited, Astellas Pharma Inc., Serum Institute of India Pvt. Ltd., GlaxoSmithKline, plc., Merck & Co., Sanofi, MedImmune, LLC, Emergent BioSolutions, Inc., Johnson & Johnson, and Pfizer, Inc.
Segmentation:
The global live attenuated vaccines market is segmented by type, vaccine development, and end users.
Global live attenuated vaccines market is segmented on the basis of type, which includes bacterial and viral vaccines. Bacterial vaccines consists of BCG vaccine, while the viral vaccine segment is further segmented into rotavirus, oral polio vaccine (OPV), measles, yellow fewer, and other viral vaccines.
By vaccine development, the market is segmented into live animals, tissue culture, and embryonated eggs.
On the basis of end users, it is sub-segmented into diagnostic centers, research institutes, hospitals, clinics, and others.
Regional Analysis:
The Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA) are key regions considered in the global live attenuated vaccines market.
The Americas is expected to lead in the market owing to the large contribution by North America. Initiatives by governments for combating diseases outbreaks such as Africa swine fever (ASF) and influenza as well as management of vaccination camps can ensure the growth of the global live attenuated vaccines market. Prevention of diseases can protect animals and not have a negative impact on trade and promise the safe consumption of meat, eggs, and milk among the masses.
Europe is the second largest region in the global live attenuated vaccines market. Rise of funding for vaccine development and outbreak of infectious diseases among livestock can trigger the need for LAVs.  Rising number of patents for alleviating ASF and Bluetongue as well as development of public-private partnerships are likely to influence the regional market growth. Increased efforts to improve the performance and efficacy of LAVs in long term controlled experiments will be witnessed in the coming years.
NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Labels:

Comments

Post a Comment

Popular posts from this blog

Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis and Forecast to 2023

Market Overview: The Global Respiratory Therapeutic Devices Market is predicted to scale to new heights and expand at a CAGR of 10.8% over the forecast period of 2017-2023, asserts Market Research Future (MRFR) in an in-depth study.                   The growth of the Global Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis   is primarily led by the recent surge in the incidence of chronic respiratory diseases such as asthma, COPD, and sleep disorder breathing. As per the estimates of the World Health Organization (WHO), approximately 235 Mn people suffered from asthma in 2017 across the globe. The growing burden of chronic respiratory diseases (CRDs) induces strong demand for respiratory therapeutic devices within the market. Moreover, with the increase in the global aging population, there is a greater need for respiratory therapeutic devices.     ...
Post a Comment
Read more

Antibody Drug Conjugate Market is Presumed to Grow at a Reliable CAGR of 19% During Forecast to 2023

Antibody Drug Conjugate Market Analysis: Various factors are adding to the global antibody drug conjugate market share. These factors, as per the new MRFR report, include advances in medical technology, rising cases of cancer, growing obese population, and increasing aging population. Additional factors adding market growth include increasing collaborations between biotechnology companies, biopharmaceuticals, and research institutes, rising R&D on oncology diseases, increasing research on advanced drug discoveries, rising number of research on antibody therapies, and preclinical research. The global Antibody Drug Conjugate Market Share is likely to grow at a 19% CAGR between 2017- 2023 , reveals the new Market Research Future (MRFR) report. Antibody drug conjugates are new-age therapeutic agents that have three parts- a chemical linker to attach cytotoxic agents to antibodies, cytotoxic agents for killing target cancer cells, and specific antibodies for binding. Lymphoma, mult...
Post a Comment
Read more

Desalting and Buffer Exchange Market is Growing at a Healthy CAGR of 10.5% During Forecast to 2023

Market Highlights: The Global Desalting and Buffer Exchange Market is anticipated to have held a market value of USD 615.20 million in the year 2017 and is expected to grow at a CAGR of 10.5% during the forecast period. Desalting and buffer exchange play a key role in biotechnological companies. Buffer exchange is used to place a protein solution into a more suitable buffer before applications such as electrophoresis, ion exchange, affinity chromatography among others. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/6633 Buffer exchange is the term used when one set of buffer salts in a sample is exchanged by another more appropriate buffer set. The rising demand for monoclonal antibodies, growing research and development expenditure by the biopharmaceutical companies, and rising focus on proteomic and genomic research is anticipated to boost the growth of the market over the forecast period. However, the dearth of skilled professionals is excepted to ...
Post a Comment
Read more